The news is by your side.

Evolus: Gaining Market Share (NASDAQ:EOLS)


Botox Treatment


Hold faithfulness and sincerity as first principles.”― Confucius.

We last visited Evolus, Inc. (NASDAQ:EOLS) one year ago. In that article, the stock was recommended as a small, covered call candidate pending further developments. The stock is down


Leave A Reply

Your email address will not be published.